This tablet is a targeted cancer medication that is primarily used for non-small cell lung cancer (NSCLC). Patients who have particular EGFR mutations may use it for treatment. Tagrisso 80mg Tablet is commonly prescribed for the advanced or metastatic conditions.
What Is Tagrisso 80mg Tablet?
It is a medicine that includes the active ingredient osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI). It is specifically designed to inhibit signals that lead to the proliferation of cancer cells that are present in patients who have EGFR mutations in lung cancer. Thereby, doctor prescribes Tagrisso Tablet for EGFR-positive lung cancer.
How Does it Work?
It inhibits EGFR mutations which stimulate tumor growth. This medication will inhibit cancer cell division, slow the spread of tumors, decrease cancer cell metastasis, and improve control over lung cancer patients.
Benefits of Tagrisso 80mg Tablet
-
Extremely effective against EGFR mutated NSCLC
-
It can be taken either early in the disease or as an advanced therapy
-
It can be easily administered at home
-
It can pass the blood-brain barrier so that the drug can treat lung cancer metastasis in the brain
-
Increased progression-free survival in the patients
Is It Safe to Take?
Although the medicine is generally well tolerated with medical supervision some patients do experience certain side effects:
-
Diarrhea
-
Loss of appetite
-
Rash
-
Stomatitis (Inflammation of the mouth)
In certain instances Regular checkups are essential during treatment.
Who Should Take It?
It can be given to patients with EGFR-positive non-small cell lung cancer. Both early and metastatic stages are treatable. The drug is not appropriate for everybody so be sure that it is suitable after consultation and genetic testing.
Important Precautions
Take the drug as per the direction given by the physician. Do not discontinue the drug therapy without the consent of the doctor. Disclose the other medication you might be taking. The cardiac function and pulmonary function have to be regularly monitored Report and adverse effects of the medication to the physician immediately.
Conclusion
It is an advanced target therapy medication for non-small cell lung cancer that has EGFR mutation. It is used for managing tumors and managing cancer development and patient survival rate. This EGFR inhibitor is very commonly used in treatment of advanced lung cancer and must be used strictly under medical supervision to get desired result and overcome the side effects. Visit the site of Globans Pharma for more information.
FAQs
What is the dosage for taking Tagrisso 80mg Tablet?
The dosage prescribed by a doctor for Tagrisso 80mg Tablet is orally once a day along with the food or without it.
Will this tablet cure lung cancer?
No, it cannot cure the lung cancer, but it can help to manage the lung cancer development along with enhancing the survival of the patient having EGFR mutation in lung cancer.
You must be logged in to post a comment.